Name | Description | Size | Catalog # | |
---|---|---|---|---|
SLIGKV-NH2 | SLIGKV-NH2 is a selective agonist of the Protease-activated receptor-2 (PA… | 100 mg | GPS-100 | More Info |
SLIGKV-NH2 | SLIGKV-NH2 is a selective agonist of the Protease-activated receptor-2 (PA… | 25 mg | GPS-100 | More Info |
SLIGKV-NH2 | SLIGKV-NH2 is a selective agonist of the Protease-activated receptor-2 (PA… | 5 mg | GPS-100 | More Info |
Slotoxin | Slotoxin inhibits the Maxi K+ (BKCa or mSlo, KCNMA1, KCa1.1) channels1. Sl… | 0.1 mg | STS-410 | More Info |
Slotoxin | Slotoxin inhibits the Maxi K+ (BKCa or mSlo, KCNMA1, KCa1.1) channels1. Sl… | 0.5 mg | STS-410 | More Info |
Slotoxin | Slotoxin inhibits the Maxi K+ (BKCa or mSlo, KCNMA1, KCa1.1) channels1. Sl… | 1 mg | STS-410 | More Info |
Slotoxin | Slotoxin inhibits the Maxi K+ (BKCa or mSlo, KCNMA1, KCa1.1) channels1. Sl… | 10 mg | STS-410 | More Info |
Slotoxin | Slotoxin inhibits the Maxi K+ (BKCa or mSlo, KCNMA1, KCa1.1) channels1. Sl… | 5 mg | STS-410 | More Info |
SNAP 37889 | SNAP 37889 is a potent GalR3 galanin receptor antagonist, highly selective… | 10 mg | S-210 | More Info |
SNAP 37889 | SNAP 37889 is a potent GalR3 galanin receptor antagonist, highly selective… | 100 mg | S-210 | More Info |
SNAP 37889 | SNAP 37889 is a potent GalR3 galanin receptor antagonist, highly selective… | 25 mg | S-210 | More Info |
SNAP 37889 | SNAP 37889 is a potent GalR3 galanin receptor antagonist, highly selective… | 50 mg | S-210 | More Info |
SNX-482 | SNX-482 blocks R-type (CaV2.3) and P / Q-type (CaV2.1) voltage-gated Ca2+… | 0.1 mg | RTS-500 | More Info |
SNX-482 | SNX-482 blocks R-type (CaV2.3) and P / Q-type (CaV2.1) voltage-gated Ca2+… | 0.25 mg | RTS-500 | More Info |
SNX-482 | SNX-482 blocks R-type (CaV2.3) and P / Q-type (CaV2.1) voltage-gated Ca2+… | 0.5 mg | RTS-500 | More Info |
SNX-482 | SNX-482 blocks R-type (CaV2.3) and P / Q-type (CaV2.1) voltage-gated Ca2+… | 1 mg | RTS-500 | More Info |
SNX-482 | SNX-482 blocks R-type (CaV2.3) and P / Q-type (CaV2.1) voltage-gated Ca2+… | 2.5 mg | RTS-500 | More Info |
SNX-482 | SNX-482 blocks R-type (CaV2.3) and P / Q-type (CaV2.1) voltage-gated Ca2+… | 25 µg | RTS-500 | More Info |
SNX-482 | SNX-482 blocks R-type (CaV2.3) and P / Q-type (CaV2.1) voltage-gated Ca2+… | 5 mg | RTS-500 | More Info |
SNX-482 | SNX-482 blocks R-type (CaV2.3) and P / Q-type (CaV2.1) voltage-gated Ca2+… | 50 µg | RTS-500 | More Info |
Spinoxin | Spinoxin is a potent blocker of KV1.2 and KV1.3 channels1. Synthetic pepti… | 0.1 mg | STS-500 | More Info |
Spinoxin | Spinoxin is a potent blocker of KV1.2 and KV1.3 channels1. Synthetic pepti… | 0.5 mg | STS-500 | More Info |
Spinoxin | Spinoxin is a potent blocker of KV1.2 and KV1.3 channels1. Synthetic pepti… | 1 mg | STS-500 | More Info |
Spinoxin | Spinoxin is a potent blocker of KV1.2 and KV1.3 channels1. Synthetic pepti… | 5 mg | STS-500 | More Info |
Spinoxin | Spinoxin is a potent blocker of KV1.2 and KV1.3 channels1. Synthetic pepti… | 50 µg | STS-500 | More Info |
SpTx-1 | SpTx-1 inhibits hKATP channels with a Kd of 15 nM by blocking the hKir6.2… | 0.5 mg | STS-800 | More Info |
SpTx-1 | SpTx-1 inhibits hKATP channels with a Kd of 15 nM by blocking the hKir6.2… | 1 mg | STS-800 | More Info |
SpTx-1 | SpTx-1 inhibits hKATP channels with a Kd of 15 nM by blocking the hKir6.2… | 10 mg | STS-800 | More Info |
SpTx-1 | SpTx-1 inhibits hKATP channels with a Kd of 15 nM by blocking the hKir6.2… | 5 mg | STS-800 | More Info |
SpTx-1 | SpTx-1 inhibits hKATP channels with a Kd of 15 nM by blocking the hKir6.2… | 50 µg | STS-800 | More Info |
SpTx-1 | SpTx-1 inhibits hKATP channels with a Kd of 15 nM by blocking the hKir6.2… | 0.1 mg | STS-800 | More Info |
SR 48527 | SR 48527, an analog of SR 48692, is a potent and selective antagonist of N… | 10 mg | S-225 | More Info |
SR 48527 | SR 48527, an analog of SR 48692, is a potent and selective antagonist of N… | 25 mg | S-225 | More Info |
SR 48527 | SR 48527, an analog of SR 48692, is a potent and selective antagonist of N… | 5 mg | S-225 | More Info |
SR 48527 | SR 48527, an analog of SR 48692, is a potent and selective antagonist of N… | 50 mg | S-225 | More Info |
SR 48692 | SR 48692 is a potent and selective non-peptide antagonist of NTS1 receptor… | 10 mg | S-265 | More Info |
SR 48692 | SR 48692 is a potent and selective non-peptide antagonist of NTS1 receptor… | 25 mg | S-265 | More Info |
SR 48692 | SR 48692 is a potent and selective non-peptide antagonist of NTS1 receptor… | 5 mg | S-265 | More Info |
SR 48692 | SR 48692 is a potent and selective non-peptide antagonist of NTS1 receptor… | 50 mg | S-265 | More Info |
SR 57227A | SR 57227A is a high affinity, selective 5-HT3 receptor agonist, active in… | 10 mg | S-155 | More Info |
SR 57227A | SR 57227A is a high affinity, selective 5-HT3 receptor agonist, active in… | 25 mg | S-155 | More Info |
SR 57227A | SR 57227A is a high affinity, selective 5-HT3 receptor agonist, active in… | 5 mg | S-155 | More Info |
SR 57227A | SR 57227A is a high affinity, selective 5-HT3 receptor agonist, active in… | 50 mg | S-155 | More Info |
SR 33805 oxalate | SR 33805, a fantofarone derivative, is a potent Ca2+ channel antagonist1.… | 10 mg | S-105 | More Info |
SR 33805 oxalate | SR 33805, a fantofarone derivative, is a potent Ca2+ channel antagonist1.… | 25 mg | S-105 | More Info |
SR 33805 oxalate | SR 33805, a fantofarone derivative, is a potent Ca2+ channel antagonist1.… | 5 mg | S-105 | More Info |
SR 33805 oxalate | SR 33805, a fantofarone derivative, is a potent Ca2+ channel antagonist1.… | 50 mg | S-105 | More Info |
SsdTx3 | SsdTx3 inhibits hKATP channels with a Kd of <300 nM by blocking the hKi… | 0.1 mg | STS-670 | More Info |
SsdTx3 | SsdTx3 inhibits hKATP channels with a Kd of <300 nM by blocking the hKi… | 0.5 mg | STS-670 | More Info |
SsdTx3 | SsdTx3 inhibits hKATP channels with a Kd of <300 nM by blocking the hKi… | 1 mg | STS-670 | More Info |
U.S.A. OFFICE
Toll free phone: 1800-618-1644 / 1800-791-3904
Toll free fax: 1888-454-7276 / 1800-791-3912